Unfavourable effects of colchicine in combination with interferon-α in the treatment of chronic hepatitis C

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 11, 2000, Pages 1459-1467

  Angelico, M ^a,b,c,d,e   Cepparulo, M ^a,b,c,d,e   Barlattani, A ^a,b,c,d,e   Liuti, A ^a,b,c,d,e   Gentile, S ^a,b,c,d,e   Hurtova, M ^a,b,c,d,e   Ombres, D ^a,b,c,d,e   Guarascio, P ^a,b,c,d,e   Rocchi, G ^a,b,c,d,e   Angelico, F ^a,b,c,d,e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c San Giacomo Hospital   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COLCHICINE;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; COLCHICINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GOUT SUPPRESSANTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED;

EID: 0033694102     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00857.x     Document Type: Article

References (37)

1. The clinical spectrum of the disease
2. Natutal history of fibrosis progression in patients with chronic hepatitis C
3. Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma
4. Statement. Management of hepatitis C
5. Recombinant interferon alpha 2-b alone or in combination with ribavirin for retreatment of interferon relapse in chronic hepatitis C
6. Interferon alpha 2-b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
7. Inhibition of hepatic fibrogenesis: A review of pharmacological candidates
8. Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices
9. Colchicine in the treatment of cirrhosis of the liver
10. Prospective trial of colchicine in primary biliary cirrhosis
11. Evaluation of colchicine therapy in primary biliary cirrhosis
12. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
13. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis
14. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis
15. A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis
16. The action of colchicine in acute gouty arthritis
17. Beta-tubulin isotypes from bovine brain have different relative stabilities
18. Inhibition of collagen secretion from bone and cultured fibroblasts by microtubular disruptive agents
19. Effect of colchicine on collagen synthesis by liver fibroblasts in murine schistosomiasis
20. The effect of colchicine on collagenase in cultures of rheumatoid sinovium
21. Colchicine therapy for familial Mediterranean fever: A doubleblind trial
22. The management of Behcet's syndrome: How are we doing?
23. Colchicine treatment of cirrhosis: Questions
24. Histological grading and staging of chronic hepatitis
25. A proposed system for the nomenclature of hepatitis C viral genotypes
26. EASL International Consensus Conference on Hepatitis C
27. Changes in liver fibrosis at the end of alpha interferon therapy and 6-18 months later in patients with chronic hepatitis C: Quantitative assessment by a morphometric method
28. A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia
29. A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patients
30. Colchicine in chronic hepatitis B. A pilot study
31. Colchicine therapy of fibrosing liver disease. Report of a randomized double-blind study
32. The effect of cytochalasin and colchicine on interferon production
33. Inhibition of interferon secretion by vinblastine
34. Post-translational events in the production of human lymphoblastoid interferon
35. Microtubule-disrupting agents reverse the inhibitory effect of interferon on mitogenesis in 3T3 cells
36. The effect of treatment with human beta-interferon on the stimulation of thymidine uptake and DNA synthesis by colchicine in human fibroblasts